SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marshall Teitelbaum who wrote (1725)1/12/1999 11:15:00 PM
From: Rick Strange   of 2205
 
Marshall, I am hopeful that we will see the start of a pilot human trial this year. Yes, therapeutic range is a major consideration as is an equally important factor that we haven't discussed...fixation of the graft material for cartilage repair. It's my understanding that ATIS, and S&N, want to deliver a cartilage repair system that will use arthroscopic surgery. Arthroscopic procedures speed healing and dramatically shorten the hospital stay...third party payers like that. ATIS develops the tissue engineering technology and S&N develops the arthroscopic tools to achieve a stable fixation of the cartilage graft.

ATIS is currently trying several methods of fixation on large animals.
If these trials or studies are successful then I think that we will go to a pilot human trial of the best combination.

This means that it is a much more complex issue than just developing the cartilage repair material and points out the symbiotic nature of the relationship between ATIS and S&N with its expertise in arthroscopic surgery tools. For those that doubt S&Ns interest in this project, consider if you will, for every dollar (or Euro) that S&N makes from the partnership from selling cartilage repair tissue, they will probably make two or more from selling the arthroscopic tools for the procedure.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News